CDC, APIN Visit ART of Medicine Department @ FETHI

The Management of Federal Teaching Hospital, Ido-Ekiti (FETHI) with the department of Medicine on Wednesday, 6 March, 2022 received a team from Center for Disease Control and Prevention (CDC) with Aids Prevention Initiative of Nigeria (APIN) led by Mrs Odafrenkhoa Oke, Dr Chris Obanubi with the APIN team led By Dr Akueshi Chidoze for assessment visit to look at the quality of care, identify gaps and render useful assistance to closing the gaps for the Project Community Program in Anti-Retroviral Therapy Clinic of Department of Medicine.

The erstwhile Chairman, Medical Advisory Committee (CMAC), Dr Idowu Adebara who represented the Chief Medical Director, Prof. Adekunle Ajayi, welcomed the visitors to the hospital with Dr Olumide Adewara, Program Coordinator, Dr Adegbamigbe O., Mr Bank-Akinnuoye, Head of Information/Corporate Affairs Department.

In his opening remarks, Dr Adebara described his presence as the representation of both the CMD and CMAC who were presently on an official assignment. He applauded Mr Ogundana for being wonderful in the programme in FETHI. He said the hospital is ready for partnership and pieces of advice from the organisations.

The semi annual report was given by Mr Ogundana, the HTS/IT focal person on behalf of the project community via a slide data analysis of the programme in the last six months.

Dr Adewara, the programme coordinator opened the floor for questions, answers and suggestions to the CDC.

Mrs Odafrenkhoa Oke commended the presentation and illustrations and said the FETHI branch of ART is doing well. She urged the hospital to do better, as she offered suggestions on how the gaps observed can be filled.

One of the CDC team members, Dr Chris Obanubi advised the hospital to keep on improving on the programme implementation, that by so doing, ART FETHI branch can be driving the entire state.

Dr Adewara gave the closing remarks and thanked the organizations for having a beautiful interaction; while Dr Adebara suggested that they should visit the newly constructed Molecular Laboratory of the hospital and see how to partner with the system.